Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
2
×
clinical trials
fda
life sciences
national
2
×
national blog main
national top stories
new york top stories
san francisco top stories
alder biopharmaceutical
allergan
american academy of neurology
amgen
atogepant
billy dunn
biogen
biohaven
bob azelby
boston blog main
boston top stories
botox
boulder/denver blog main
boulder/denver top stories
brian abrahams
calcitonin gene-related peptide
detroit blog main
detroit top stories
drug prices
drug pricing
drugs
eli lilly
eptinezumab
erenumab
europe top stories
evrysdi
fremanezumab
galcanezumab
gene therapy
genentech
impel neuropharma
What
drug
fda
2
×
new
oral
2
×
approval
approved
arguments
atrophy
big
class
commercialized
companies
competitors
daily
decades
drugs
evrysdi
friday
green
home
intended
lights
liquid
make
medicine
meeting
migraine
muscular
neuro
patients
potential
risdiplam
roche
spinal
therapies
therapy
won
year
Language
unset
Current search:
national
×
biotech
×
fda
×
oral
×
@xconomy.com
3 years ago
FDA Green-Lights Roche Spinal Muscular Atrophy Drug, First Oral Therapy
@xconomy.com
5 years ago
At Big Neuro Meeting, Migraine Drug Competitors to Make Oral Arguments